Skip to main content

Prophylaxe der schizoaffektiven Psychosen

  • Chapter
Die Lithiumtherapie
  • 55 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • American Psychiatric Association (1989) Diagnostisches and Statistisches Manual Psychischer Storungen DSM-III-R. Beltz, Weinheim

    Google Scholar 

  • American Psychiatric Association (1996) Diagnostisches and Statistisches Manual Psychischer Storungen DSM-IV Hogrefe, Gottingen

    Google Scholar 

  • Angst J, Dittrich A, Grof P (1969) The course of endogenous affective psychoses and its modification by prophylactic administration of imipramine and lithium. Int Pharmacopsychiatr 2: 1–11

    Article  Google Scholar 

  • Angst J, Weiss P, Grof P, Baastrup PC, Schou M (1970) Lithium prophylaxis in recurrent affective disorders. Brit J Psychiat 116: 604–619

    Article  PubMed  CAS  Google Scholar 

  • Banov MD, Zarate CA, Scialabba BA, Tohen M, Wines J (1993) Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. American Psychiatric Association Annual Meeting, San Francisco, Abstract 163 Bellaire W, Demisch K, Stoll KD (1990) Carbamazepin versus Lithium. M Med Wschr 132: 82–86

    Google Scholar 

  • Brown R (1989) US experience with valproate in manic depressive illness. A multicenter trial. J Clin Psychiatr 50 (suppl): 3

    Google Scholar 

  • Delva NJ, Letemendia FJJ (1982) Lithium treatment in schizophrenia and schizoaffective disorders. Br J Psychiat 141: 387–400

    Article  CAS  Google Scholar 

  • Denicoff KD, Meglathery SB, Post RM, Tandeciarz SI (1994) Efficacy of carbamazepine compared with other agents: a clinical practice survey. J Clin Psychiatry 55: 70–76

    PubMed  CAS  Google Scholar 

  • Egli H (1971) Erfahrungen mit der Lithiumprophylaxe phasischer affektiver Erkrankungen in einer psychiatrischen Poliklinik. Schweiz Med Wschr 101: 157–164

    PubMed  CAS  Google Scholar 

  • Goodnick PJ, Meltzer HY (1984) Treatment of schizoaffective disorders. Schiz Bull 10: 30–48

    CAS  Google Scholar 

  • Greil W, Ludwig-Mayerhofer W, Erazo N, Engel RR, Czernik A, Giedke H, Müller-Oer-linghausen B, Osterheider M, Rudolf GAE, Sauer H, Tegeler J, Wetterling T (1997) Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: a randomised study. Eur Arch Psychiatry Clin Neurosci 247: 42–50

    Article  PubMed  CAS  Google Scholar 

  • Hofmann G, Kremser M, Katschnig H (1970) Prophylaktische Lithiumtherapie bei manisch-depressivem Krankheitsgeschehen and bei Legierungspsychosen. Int Pharmacopsychiat 4: 187–193

    Google Scholar 

  • Keck PE, jr, McElroy SL, Strakowski SM, West SA (1994) Pharmacologic treatment of schizoaffective disorder. Psychopharmacology 114: 529–538

    Article  PubMed  Google Scholar 

  • Küfferle B, Lenz G (1983) Classification and course of schizoaffective psychoses Follow-up of patients treated with lithium. Psychiat Clin 16: 169–177

    Google Scholar 

  • Lambert PA (1984) Acute and prophylactic therapies of patients with affective disorders using valpromide (dipropylacetamide). In: Emrich HM, Okuma T, Moller AA (eds) Anticonvulsants in affective disorders. Excerpta Medica, Amsterdam, pp. 3344

    Google Scholar 

  • Lenz G, Lovrek A, Thau K, Topitz A, Denk E, Simhandl C, Wancata J, Wolf R (1987) Zur Lithiumprophylaxe schizoaffektiver Storungen. Wiener Med Wschr 137: 5–6

    Google Scholar 

  • Maj M (1988) Lithium prophylaxis of schizoaffective disorders: a prospective study. J Aff Disord 14: 129–135

    Article  CAS  Google Scholar 

  • Mattes JA, Nayak D (1984) Lithium versus fluphenazine for prophylaxis in mainly schizophrenic schizoaffectives. Biol Psychiat 19: 445–449

    PubMed  CAS  Google Scholar 

  • McElroy SL, Keck PE, Jr, Pope HG Jr (1987) Sodium valproate: its use in primary psychiatric disorders. J Clin Psychopharmacol 7: 16–24

    PubMed  CAS  Google Scholar 

  • McElroy SL, Dessain EC, Pope HG, jr, Cole JO, Keck PE, jr, Frankenberg FR, Aizley HG, O’Brien S (1991) Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder and schizophrenia. J Clin Psychiatr 52: 411–414

    CAS  Google Scholar 

  • McElroy SL, Keck PE (1993) Treatment guidelines for valproate in bipolar and schizo-affective disorders. Can J Psychiatr 38 (suppl 2): 62–66

    Google Scholar 

  • Möller HJ (1987) Indikation and Differentialindikation der neuroleptischen Langzeit-medikation. In: Pichot P, Moller HJ (eds) Neuroleptika, Ruckschau 1952-1986 — Künftige Entwicklungen. Springer, Berlin Heidelberg New York, 63–79

    Google Scholar 

  • Naber D, Hippius H (1980) The European experience with use of clozapine. Hosp Commun Psychiatry 41: 886–890

    Google Scholar 

  • Perris C (1978) Morbidity suppressive effect of lithium carbonate in cycloid psychosis. Arch Gen Psychiat 35: 328–331

    Google Scholar 

  • Placidi GF, Lenzi A, Lazzerini F, Cassano GB, Akiskal HS (1986) The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3year trial in 83 patients. J Clin Psychiatr 47: 490–494

    CAS  Google Scholar 

  • Prien RF, Caffey EM Klett CJ (1974) Factors associated with treatment success in lithium carbonate prophylaxis. Arch Gen Psychiatr 31: 189–192

    PubMed  CAS  Google Scholar 

  • Puzynski S, Klosiewicz L (1984) Valproic acid amide as a prophylactic agent in affective and schizoaffective disorders. Psychopharmacol Bull 20: 151–159

    PubMed  CAS  Google Scholar 

  • Rosenthal NE, Rosenthal LN, Stallone F, Dunner DL, Fieve RR (1980) Toward the vali-dation of RDC schizoaffective disorder. Ach Gen Psychiat 37: 804–810

    CAS  Google Scholar 

  • Smulevitch AB, Zavidovskaya GI, Igonin AK, Mikhailova M (1974) The effectiveness of lithium in affective and schizoaffective psychoses. Brit J Psychiat 125: 65–72

    Article  PubMed  CAS  Google Scholar 

  • Spitzer RK, Endicott J, Robins E (1982) Forschungs-Diagnose-Kriterien ( RDC) Beltz, Weinheim Basel

    Google Scholar 

  • Tress W, Haag H (1979) Vergleichende Erfahrungen mit der rezidivprophylaktischen Lithium- Langzeitmedikation bei schizoaffektiven Psychosen. Nervenarzt 50: 524–526

    PubMed  CAS  Google Scholar 

  • Weltgesundheitsorganisation (1991) Internationale Klassifikation psychischer St6rungen, ICD-10, Kapitel V Klinisch-diagnostische Leitlinien, Huber, Bern

    Google Scholar 

  • Zarate CA, Tohen M, Banov MD, Weiss MK, Cole JO (1995) Is clozapine a mood stabilizer? J Clin Psychiatry 56: 108–112

    PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lenz, G., Bankier, B. (1997). Prophylaxe der schizoaffektiven Psychosen. In: Müller-Oerlinghausen, B., Berghöfer, A., Greil, W. (eds) Die Lithiumtherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60819-3_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60819-3_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64570-9

  • Online ISBN: 978-3-642-60819-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics